molecules of the month


oral G2019S-LRRK2 mut.-selective kinase inh.

>70x sel. for ParkinsonÕs mut. over WT, non-BP

from 50k cmpd HTS + homology-based opt.

J. Med. Chem., Nov. 16, 2020

ESCAPE Bio, South San Francisco, CA

Structure of EB-42486 - a potent, oral inhibitor of leucine-rich repeat kinase 2 (LRRK2)
1 min read

EB-42486 (ESCAPE Bio oral G2019S-LRRK2 mutant-selective kinase inhibitor)

request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.

already a member? log in: